216311-57-8Relevant articles and documents
ORGANIC ARSENIC-BASED TYPE II PYRUVATE KINASE INHIBITOR AS WELL AS PREPARATION METHOD THEREFOR AND USE THEREOF
-
, (2022/04/08)
Provided by the present invention are an organic arsenic-based type II pyruvate kinase inhibitor as well as a preparation method therefor and a use thereof. Specifically, a PKM2 inhibitor of the present invention is a compound represented by formula I, or a pharmaceutically acceptable salt thereof, or a stereoisomer or tautomer, a hydrate or a solvate thereof, wherein, X1, X2, R1, R2, R3, R4, R5 and n are as defined in the description. The compound of the present invention has a high inhibitory activity and high specificity for PKM2 and is well suited for the preparation of a drug inhibiting tumors by inhibiting a PKM2 pathway.
Synthesis and antibacterial activity of the C-7 side chain of 3-aminoquinazolinediones
Hutchings, Kim M.,Tran, Tuan P.,Ellsworth, Edmund L.,Watson, Brian M.,Sanchez, Joseph P.,Hollis Showalter,Stier, Michael A.,Shapiro, Martin,Themis Joannides,Huband, Michael,Nguyen, Dai Q.,Maiti, Samarendra,Li, Tingsheng,Tailor, Jyoti,Thomas, George,Ha, Chan,Singh, Rajeshwar
scheme or table, p. 5087 - 5090 (2009/05/07)
A novel series of bacterial topoisomerase (3-aminoquinazolinediones) inhibitors are described. The side-chain SAR against Gram-positive and Gram-negative organisms as well as DNA gyrase activity is reported.
Angiotensin II antagonists
-
, (2008/06/13)
This invention provides novel heterocyclic derivatives, their pharmaceutical formulations, and their use for antagonizing angiotensin II receptors in mammals.